| Mrs Haley Elise Sziszak, APRN, FNP-C | |
|
1065 Skyline Dr, Conway, AR 72032-3530 | |
| (501) 499-6222 | |
| Not Available |
| Full Name | Mrs Haley Elise Sziszak |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 4 Years |
| Location | 1065 Skyline Dr, Conway, Arkansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144807488 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 214751 (Arkansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Conway Regional Health System | Conway, AR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| William H. Freeman, M.d., P.a. | 2668505215 | 6 |
News Archive
Aquavit Life Sciences, Inc., a wholly owned subsidiary of Aquavit Pharmaceuticals, Inc., announces together with Uniquest Corporation (KOSPI: 077500) a Memorandum Of Understanding to form an Alliance Partnership for the development, registration and manufacturing of Aquavit Pharmaceuticals' PITO-001.
A tool intended to detect signs of autism in high-risk infants can be used to help identify and treat patients with tuberous sclerosis complex (TSC), a genetic disorder, who most need early intervention. Moreover, they can identify these patients earlier than ever before.
The international ATOLL study sponsored by the Assistance Publique - Hopitaux de Paris showed that enoxaparin reduced the composite of death, complication of myocardial infraction, procedure failure or major bleeding by 17% in comparison with standard heparin death, recurrent acute coronary syndrome or urgent revascularisation. The results of the ATOLL study were presented at the hotline session of the annual European Cardiology Congress (ESC 2010) in Stockholm, Sweden.
20/20 GeneSystems, Inc. announced today at ADAPT 2010, an industry meeting focusing on advancing personalized medicine, the commercial launch of their patented technology for biomarker identification in tumors and other tissue samples. 20/20 is currently offering the technology to industry and academic researchers under service contracts.
The rapid spread of SARS-CoV-2 across the world despite the early shutdown of borders and the cessation of international travel has sparked interest and given rise to changes in knowledge regarding the spread of infections.
› Verified 4 days ago
| Entity Name | William H. Freeman, M.d., P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982721882 PECOS PAC ID: 2668505215 Enrollment ID: O20100803000318 |
News Archive
Aquavit Life Sciences, Inc., a wholly owned subsidiary of Aquavit Pharmaceuticals, Inc., announces together with Uniquest Corporation (KOSPI: 077500) a Memorandum Of Understanding to form an Alliance Partnership for the development, registration and manufacturing of Aquavit Pharmaceuticals' PITO-001.
A tool intended to detect signs of autism in high-risk infants can be used to help identify and treat patients with tuberous sclerosis complex (TSC), a genetic disorder, who most need early intervention. Moreover, they can identify these patients earlier than ever before.
The international ATOLL study sponsored by the Assistance Publique - Hopitaux de Paris showed that enoxaparin reduced the composite of death, complication of myocardial infraction, procedure failure or major bleeding by 17% in comparison with standard heparin death, recurrent acute coronary syndrome or urgent revascularisation. The results of the ATOLL study were presented at the hotline session of the annual European Cardiology Congress (ESC 2010) in Stockholm, Sweden.
20/20 GeneSystems, Inc. announced today at ADAPT 2010, an industry meeting focusing on advancing personalized medicine, the commercial launch of their patented technology for biomarker identification in tumors and other tissue samples. 20/20 is currently offering the technology to industry and academic researchers under service contracts.
The rapid spread of SARS-CoV-2 across the world despite the early shutdown of borders and the cessation of international travel has sparked interest and given rise to changes in knowledge regarding the spread of infections.
› Verified 4 days ago
| Entity Name | Urgent Team Of Arkansas Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992041370 PECOS PAC ID: 1850539198 Enrollment ID: O20130529000209 |
News Archive
Aquavit Life Sciences, Inc., a wholly owned subsidiary of Aquavit Pharmaceuticals, Inc., announces together with Uniquest Corporation (KOSPI: 077500) a Memorandum Of Understanding to form an Alliance Partnership for the development, registration and manufacturing of Aquavit Pharmaceuticals' PITO-001.
A tool intended to detect signs of autism in high-risk infants can be used to help identify and treat patients with tuberous sclerosis complex (TSC), a genetic disorder, who most need early intervention. Moreover, they can identify these patients earlier than ever before.
The international ATOLL study sponsored by the Assistance Publique - Hopitaux de Paris showed that enoxaparin reduced the composite of death, complication of myocardial infraction, procedure failure or major bleeding by 17% in comparison with standard heparin death, recurrent acute coronary syndrome or urgent revascularisation. The results of the ATOLL study were presented at the hotline session of the annual European Cardiology Congress (ESC 2010) in Stockholm, Sweden.
20/20 GeneSystems, Inc. announced today at ADAPT 2010, an industry meeting focusing on advancing personalized medicine, the commercial launch of their patented technology for biomarker identification in tumors and other tissue samples. 20/20 is currently offering the technology to industry and academic researchers under service contracts.
The rapid spread of SARS-CoV-2 across the world despite the early shutdown of borders and the cessation of international travel has sparked interest and given rise to changes in knowledge regarding the spread of infections.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Haley Elise Sziszak, APRN, FNP-C 161 Blackjack Rd, Greenbrier, AR 72058-9584 Ph: (501) 215-1223 | Mrs Haley Elise Sziszak, APRN, FNP-C 1065 Skyline Dr, Conway, AR 72032-3530 Ph: (501) 499-6222 |
News Archive
Aquavit Life Sciences, Inc., a wholly owned subsidiary of Aquavit Pharmaceuticals, Inc., announces together with Uniquest Corporation (KOSPI: 077500) a Memorandum Of Understanding to form an Alliance Partnership for the development, registration and manufacturing of Aquavit Pharmaceuticals' PITO-001.
A tool intended to detect signs of autism in high-risk infants can be used to help identify and treat patients with tuberous sclerosis complex (TSC), a genetic disorder, who most need early intervention. Moreover, they can identify these patients earlier than ever before.
The international ATOLL study sponsored by the Assistance Publique - Hopitaux de Paris showed that enoxaparin reduced the composite of death, complication of myocardial infraction, procedure failure or major bleeding by 17% in comparison with standard heparin death, recurrent acute coronary syndrome or urgent revascularisation. The results of the ATOLL study were presented at the hotline session of the annual European Cardiology Congress (ESC 2010) in Stockholm, Sweden.
20/20 GeneSystems, Inc. announced today at ADAPT 2010, an industry meeting focusing on advancing personalized medicine, the commercial launch of their patented technology for biomarker identification in tumors and other tissue samples. 20/20 is currently offering the technology to industry and academic researchers under service contracts.
The rapid spread of SARS-CoV-2 across the world despite the early shutdown of borders and the cessation of international travel has sparked interest and given rise to changes in knowledge regarding the spread of infections.
› Verified 4 days ago
Marina Gray, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 495 Hogan Ln Ste 2, Conway, AR 72034 Phone: 501-358-6695 Fax: 501-358-6860 | |
Mckenzie Lauren Cotton, APRN, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1065 Skyline Dr, Conway, AR 72032 Phone: 501-499-6222 | |
Cynthia Lou Grubbs, APN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 495 Hogan Ln, Conway, AR 72034 Phone: 501-327-1150 Fax: 501-327-3427 | |
Mrs. Leah Maranda Martin, ANP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1014 Harkrider St, Suite B, Conway, AR 72032 Phone: 501-327-7100 Fax: 501-279-9011 | |
Keisha A. Fox, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 350 Salem Rd Ste 1, Conway, AR 72034 Phone: 479-518-4977 Fax: 479-203-3030 | |
Mrs. Shakenia A Tate, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 150 E Siebenmorgen Rd, Conway, AR 72032 Phone: 501-329-6851 | |
David Adam Steinfeld, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 855 S German Ln Ste 1, Conway, AR 72034 Phone: 501-358-6606 Fax: 501-325-5554 |